Emerging concepts in the therapy of mitochondrial disease

Biochimica Et Biophysica Acta
Carlo ViscomiMassimo Zeviani

Abstract

Mitochondrial disorders are an important group of genetic conditions characterized by impaired oxidative phosphorylation. Mitochondrial disorders come with an impressive variability of symptoms, organ involvement, and clinical course, which considerably impact the quality of life and quite often shorten the lifespan expectancy. Although the last 20 years have witnessed an exponential increase in understanding the genetic and biochemical mechanisms leading to disease, this has not resulted in the development of effective therapeutic approaches, amenable of improving clinical course and outcome of these conditions to any significant extent. Therapeutic options for mitochondrial diseases still remain focused on supportive interventions aimed at relieving complications. However, new therapeutic strategies have recently been emerging, some of which have shown potential efficacy at the pre-clinical level. This review will present the state of the art on experimental therapy for mitochondrial disorders.

References

May 18, 1989·The New England Journal of Medicine·C T MoraesS Servidei
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y G KimS Chandrasegaran
Aug 15, 1996·European Journal of Biochemistry·R D MartinusN J Hoogenraad
Jan 19, 2000·Gene Therapy·P F ChinneryR N Lightowlers
Feb 13, 2001·Neuromuscular Disorders : NMD·I NishinoM Hirano
Dec 26, 2001·The Journal of Biological Chemistry·Antonella SpinazzolaMichio Hirano
Aug 23, 2002·Proceedings of the National Academy of Sciences of the United States of America·Guang-Ping GaoJames M Wilson
Aug 29, 2002·The EMBO Journal·Quan ZhaoNicholas J Hoogenraad
Sep 28, 2002·Nature·Jeffrey A KleinSusan L Ackerman
Mar 30, 2004·Annals of Neurology·Patrick G SullivanJong M Rho
Jul 27, 2004·Nature Medicine·Paul GregorevicJeffrey S Chamberlain
Sep 25, 2004·Annals of Neurology·Sumana SantraEric A Schon
May 10, 2005·Science·Samuel E SchrinerPeter S Rabinovitch
Sep 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Maria Pilar Bayona-BafaluyCarlos T Moraes
Jun 30, 2006·Annals of Neurology·Kristopher J BoughRaymond J Dingledine
Jul 4, 2006·Brain : a Journal of Neurology·Tina D JeppesenJohn Vissing
Feb 13, 2007·Apoptosis : an International Journal on Programmed Cell Death·Andrea Rasola, Paolo Bernardi
May 23, 2007·Neurology·Shamima Rahman, Iain P Hargreaves
Nov 17, 2007·Genes & Development·Noboru Mizushima
Mar 26, 2008·Proceedings of the National Academy of Sciences of the United States of America·Luciano MerliniPaolo Bernardi
Apr 9, 2008·Physiological Reviews·Richard C Scarpulla
May 10, 2008·Journal of Neurochemistry·Stuart G JarrettManisha Patel
Jul 16, 2008·Biochimica Et Biophysica Acta·Erika Fernández-VizarraMassimo Zeviani

❮ Previous
Next ❯

Citations

Dec 19, 2015·Mitochondrial DNA. Part A. DNA Mapping, Sequencing, and Analysis·Dan LanYiping Liu
Nov 3, 2015·Expert Opinion on Therapeutic Targets·Marina Villanueva PazJosé A Sánchez-Alcázar
Nov 1, 2015·The Canadian Journal of Cardiology·Catherine Brunel-GuittonFlorin Sasarman
May 1, 2015·Medical Science Monitor Basic Research·Fabio TasceddaEnzo Ottaviani
May 3, 2016·Nutrients·Jean Bastin, Fatima Djouadi
Aug 10, 2016·Frontiers in Cardiovascular Medicine·Ayman W El-Hattab, Fernando Scaglia
Sep 23, 2016·Nature·Jinke GuMaojun Yang
Oct 22, 2016·Scientific Reports·Tanja MacheinerKarine Sargsyan
Nov 15, 2016·Expert Review of Neurotherapeutics·Alberto VerrottiGiangennaro Coppola
Jan 18, 2017·Cell Metabolism·Timo E S KauppilaNils-Göran Larsson
Feb 2, 2017·The Journal of Clinical Investigation·Ana L MoraMauricio Rojas
Nov 22, 2017·Annals of the American Thoracic Society·Sunad RangarajanVictor J Thannickal
Jul 4, 2018·British Journal of Pharmacology·Binh Yen NguyenWei Liu
Nov 15, 2018·Physiological Reviews·Lars LarssonMarco Sandri
Jun 10, 2016·Journal of Inherited Metabolic Disease·Saskia KoeneJan A M Smeitink
Feb 12, 2019·Critical Reviews in Biochemistry and Molecular Biology·Désirée Schatton, Elena I Rugarli
Oct 12, 2018·Biochemical Society Transactions·Caterina Garone, Carlo Viscomi
Apr 6, 2019·Journal of Cellular Physiology·Teresa Galera-MongeMaría Esther Gallardo
Jan 27, 2019·Practical Neurology·Lina NashefElaine Murphy
Mar 10, 2016·EMBO Molecular Medicine·Werner Jh KoopmanJan Am Smeitink
Apr 14, 2019·EMBO Molecular Medicine·Alessia IndrieriBrunella Franco
Nov 4, 2016·EMBO Molecular Medicine·Robert Ds Pitceathly, Carlo Viscomi
Oct 13, 2018·EMBO Molecular Medicine·Gabriele CivilettoMassimo Zeviani
Aug 7, 2019·Critical Care Medicine·Scott L WeissDouglas C Wallace
Sep 27, 2018·Nature Medicine·Payam A GammageMichal Minczuk
Nov 4, 2017·Annual Review of Pathology·Adam J KuszakZarazuela Zolkipli-Cunningham
Mar 20, 2019·EMBO Molecular Medicine·Karthik MohanrajAgnieszka Chacinska
May 6, 2020·International Journal of Molecular Sciences·Teresa Galera-MongeM Esther Gallardo
Dec 3, 2016·Biochemical Society Transactions·Carlo Viscomi
Jun 18, 2017·Biochemical Society Transactions·Benjamin MayAnthony L Moore
Jan 13, 2021·Neural Regeneration Research·Isaac G OnyangoGorazd B Stokin
Jul 3, 2021·International Journal of Molecular Sciences·Lara CoppiMaurizio Crestani
Aug 17, 2021·Wellcome Open Research·Aura Cecilia Jimenez-MorenoGrainne S Gorman
Sep 19, 2021·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Mureo KasaharaKei Murayama

❮ Previous
Next ❯

Related Concepts

Related Feeds

ATP Synthases

ATP synthases are enzymes located in the inner mitochondrial membrane that catalyze the synthesis of ATP during cellular respiration. Discover the latest research on ATP synthases here.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Autophagosome

An autophagosome is the formation of double-membrane vesicles that involve numerous proteins and cytoplasmic components. These double-membrane vesicles are then terminated at the lysosome where they are degraded. Discover the latest research on autophagosomes here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

The Indian Journal of Medical Research
Nahid Akhtar KhanKumarasamy Thangaraj
Frontiers in Bioscience (Elite Edition)
Shamayel MohammedConsolato Sergi
© 2021 Meta ULC. All rights reserved